Adtalem Global Education (NYSE:CVSA) Updates FY 2027 Earnings Guidance

Adtalem Global Education (NYSE:CVSA) updated its FY 2027 earnings guidance on Thursday. The company provided earnings per share guidance of 8.900-9.150 for the period, compared to the consensus earnings per share estimate of 8.880. The company issued revenue guidance of $2.1 billion-$2.1 billion, compared to the consensus revenue estimate of $2.1 billion.

Adtalem Global Education Stock Down 3.0%

CVSA traded down $3.81 during trading hours on Thursday, hitting $125.10. The stock had a trading volume of 547,627 shares, compared to its average volume of 369,634. Adtalem Global Education has a 1 year low of $86.97 and a 1 year high of $156.26. The firm’s fifty day simple moving average is $124.15. The stock has a market capitalization of $4.26 billion, a PE ratio of 19.49, a PEG ratio of 0.98 and a beta of 0.62. The company has a debt-to-equity ratio of 0.36, a quick ratio of 0.70 and a current ratio of 0.70.

Adtalem Global Education (NYSE:CVSA) last issued its earnings results on Thursday, August 6th. The company reported $2.09 earnings per share for the quarter, topping analysts’ consensus estimates of $1.90 by $0.19. Adtalem Global Education had a net margin of 12.26% and a return on equity of 20.19%. The firm had revenue of $501.38 million during the quarter. Adtalem Global Education has set its FY 2027 guidance at 8.900-9.150 EPS. As a group, equities analysts expect that Adtalem Global Education will post 8.04 EPS for the current year.

Analyst Ratings Changes

A number of equities analysts have recently commented on the company. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Adtalem Global Education in a report on Friday, May 22nd. Truist Financial raised their target price on Adtalem Global Education from $130.00 to $140.00 and gave the stock a “buy” rating in a research note on Monday, May 11th. Barrington Research reiterated an “outperform” rating and set a $170.00 price target on shares of Adtalem Global Education in a research report on Monday, June 8th. Finally, Wall Street Zen downgraded shares of Adtalem Global Education from a “buy” rating to a “hold” rating in a report on Saturday, July 25th. Two analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $155.00.

Insiders Place Their Bets

In related news, SVP Douglas G. Beck sold 9,615 shares of the company’s stock in a transaction that occurred on Friday, May 8th. The shares were sold at an average price of $127.03, for a total value of $1,221,393.45. Following the transaction, the senior vice president directly owned 38,159 shares in the company, valued at approximately $4,847,337.77. This represents a 20.13% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Robert J. Phelan sold 10,000 shares of Adtalem Global Education stock in a transaction that occurred on Friday, May 8th. The shares were sold at an average price of $126.21, for a total transaction of $1,262,100.00. Following the sale, the chief financial officer owned 55,806 shares of the company’s stock, valued at approximately $7,043,275.26. The trade was a 15.20% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 53,183 shares of company stock valued at $6,914,570 over the last 90 days. 2.50% of the stock is owned by insiders.

Adtalem Global Education Company Profile

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.